ArticlePloS one2025
Grape seed proanthocyanidin extract inhibits ferroptosis by activating Nrf2/HO-1 and protects against diabetic kidney disease.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe main pathological characteristic of diabetic kidney disease (DKD) is renal dysfunction caused by tubular injury. Ferroptosis is a recently discovered form of cell death closely linked to renal tubular injury in DKD. Nuclear factor erythroid-2 related factor 2/heme oxygenase 1(Nrf2/HO-1) is crucial in controlling ferroptosis. Grape seed proanthocyanidin extract (GSPE) mitigates renal dysfunction in DKD by activating Nrf2/HO-1 pathway. However, the role of GSPE in protecting against DKD through ferroptosis modulation has been insufficiently explored.
methodsStreptozotocin (STZ)-induced diabetic rat models and HK2 cells cultured with high glucose were used as experimental objects in this study. HE and PAS staining was used to observe the morphological changes of rat kidney. Fe2+ and reactive oxygen species (ROS) levels as well as apoptosis were determined by fluorescent staining. Transferrin receptor protein 1(TfR1), acylcoa synthetase long chain family member 4(ACSL4), glutathione peroxidase 4 (GPX4), Nrf2 and HO-1 proteins were detected by western blot. Subsequently, Nrf2 was knocked down and oxidative stress and ferroptosis were observed in HK2 cells.
resultsIn vivo and vitro result showed that GSPE treatment significantly lessened renal impairment, oxidative stress, and ferroptosis in DKD, while the application of Ferrostatin-1 (Fer-1) notably amplified the anti-ferroptotic effect of GSPE. Moreover, the anti-ferroptotic effect of GSPE was markedly diminished after Nrf2 expression was downregulated in HK2 cells.
conclusionGSPE treatment reduced ferroptosis in DKD by modulating the Nrf2/HO-1. In conclusion, our results underscore the significance of ferroptosis in DKD and present new perspectives on the protective effects of GSPE in this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.